Products for Research Use Only

DOV-102,677

CAT: 0804-HY-18332BSize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-18332BSize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DOV-102,677 is an orally sctive triple monoamine neurotransmitter reuptake inhibitor that simultaneously inhibits the dopamine (DAT) (IC50 = 129 nM; Ki = 222 nM), norepinephrine (NET) (IC50 = 103 nM; Ki = 1030 nM), and serotonin (SERT) (IC50 = 133 nM; Ki = 740 nM) transporters. DOV-102,677 demonstrated significant antidepressant-like activity and sensory-motor gating regulatory effects in mouse experiments. DOV-102,677 can be used for research on depression[1].
CAS Number
410074-75-8
UNSPSC
12352005
Target
5-HT Receptor; Adrenergic Receptor; Dopamine Transporter
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
ClC1=CC=C([C@@]23CNC[C@]2([H])C3)C=C1Cl
Molecular Formula
C11H11Cl2N
Molecular Weight
228.12
References & Citations
[1] Shao L, et al. Discovery of N-methyl-1- (1-phenylcyclohexyl) methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor. Bioorg Med Chem Lett. 2011 Mar 1;21 (5) :1438-41|[2]Prins J, et al. The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats. Eur J Pharmacol. 2010 May 10;633 (1-3) :55-61
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported